Anastasia Chrysostomou

Clinical benefits of Tocilizumab inCOVID-19-related cytokine release syndrome in a patient with end-stage kidney disease on haemodialysis in Australia

Shiny Stephen, Yeung-Ae Park, Anastasia Chrysostomou

Journal article  |  2020  |  NEPHROLOGY

COVID-19 remains a global pandemic with more than 10 million cases and half a million deaths worldwide. The disease manifestations..

Successful treatment of HIV-associated lupus-like glomerulonephritis with mycophenolic acid

Mark Tiong, Scott Wilson, Alan Pham, Anastasia Chrysostomou

Journal article  |  2020  |  CLINICAL CASE REPORTS

HIV-associated lupus-like glomerulonephritis is an uncommon but well-described entity. Treatment has traditionally focused on cont..

Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus

FB Vincent, R Kandane-Rathnayake, AY Hoi, L Slavin, JD Godsell, AR Kitching, J Harris, CL Nelson, AJ Jenkins, A Chrysostomou, ML Hibbs, PG Kerr, M Rischmueller, F Mackay, EF Morand

Journal article  |  2018  |  LUPUS

INTRODUCTION: We examined the clinical relevance of urinary concentrations of B-cell-activating factor of the tumour necrosis fact..

Increasing Prevalence and Risk of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Individuals: Changing Demographics Over a 6-Year Period

Michael A Moso, Emily Woolnough, Freya Langham, Jennifer F Hoy, Allen C Cheng, Rowan G Walker, Anastasia Chrysostomou, Ian Woolley, Achini Weeraratne, Janine M Trevillyan

Journal article  |  2018  |  JOURNAL OF INFECTIOUS DISEASES

Aldosterone in clinical nephrology-old hormone, new questions

Gavin J Becker, Tim D Hewitson, Anastasia Chrysostomou

Journal article  |  2009  |  NEPHROLOGY DIALYSIS TRANSPLANTATION

Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker

Anastasia Chrysostomou, Eugenia Pedagogos, Lachlan MacGregor, Gavin J Becker

Journal article  |  2006  |  CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Studies have shown that dual therapy with angiotensin-converting enzyme inhibitors (ACEI) and either angiotensin II receptor block..

Lymphocytic hypophysitis: a rare cause of hypoglycaemia in a man with type 2 diabetes mellitus

P Lee, A Chrysostomou, B Tress, PR Ebeling

Journal article  |  2005  |  INTERNAL MEDICINE JOURNAL

Lymphocytic hypophysitis is a primary inflammatory disorder of the pituitary gland, which may cause panhypopituitarism. The majori..

Spironolactone and ACE inhibition in chronic renal failure - Reply

A Chrysostomou, G Becker

Journal article  |  2002  |  NEW ENGLAND JOURNAL OF MEDICINE

Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease.

A Chrysostomou, G Becker

Journal article  |  2001  |  NEW ENGLAND JOURNAL OF MEDICINE

Stones in urinary tract infection

A Chrysostomou, GJ Becker

Journal article  |  1996  |  Current Therapeutics